医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

3M Responds to Inaccurate Reporting on Alleged Seizure of N95 Respirator Shipments

2020年04月06日 AM05:11
このエントリーをはてなブックマークに追加


 

ST. PAUL, Minn.

3M issued the following statement in response to inaccurate media reports alleging a shipment of 3M personal protective equipment (PPE) was seized and diverted by U.S. authorities on Friday, April 3, while in transit from a 3M China facility to Berlin Police:

“3M has no evidence to suggest 3M products have been seized. 3M has no record of any order of respirators from China for the Berlin police. We cannot speculate where this report originated.”

3M has extended an offer of help to the German authorities to try to determine if this false report is the result of fraudulent activity. We have extended this offer to all countries seeking to verify the authenticity of offers to sell respirators. 3M is committed to combating any illegal activity in connection with our products and the COVID-19 outbreak and is working with law enforcement to identify and punish perpetrators.

3M will continue to correct misinformation about our efforts to manufacture and distribute these products globally.

3M will continue to maximize the amount of respirators we can produce for heroic healthcare workers in the U.S. and worldwide, as we have done so since January when this global crisis began.

About 3M
At 3M, we apply science in collaborative ways to improve lives daily. With $32 billion in sales, our 96,000 employees connect with customers all around the world. Learn more about 3M’s creative solutions to the world’s problems at www.3M.com or on Twitter @3M or @3MNews.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200405005027/en/

CONTACT

Jennifer Ehrlich

651-733-8805

同じカテゴリーの記事 

  • 佐賀大学とBostonGeneがEGFR陽性肺癌患者におけるICIの治療効果予測因子を特定するための新規バイオマーカー探索を目的とした研究を発表
  • KBI Biopharma任命Jean-Baptiste Agnus为首席商务官
  • First Interim Analysis of PROSPER Study Details Patient-Reported Symptom Burden of Mycosis Fungoides and Sézary Syndrome
  • Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024
  • LabVantage Celebrates Customer Success with Record Number of Software Deployments in FY 2024